Tatsuya Nagano

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Topics

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Tyrosine Kinase

Top Venues

International journal of molecular sciences

Antioxidants (Basel, Switzerland)

Respiratory research

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroki Satoh, Tatsuya Nagano, Shintaro Izumi, Jun Yamada, Daisuke Hazama, Naoko Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Yoshihiro Nishimura, Kazuyuki Kobayashi
Prospective observational study of 2 wearable strain sensors for measuring the respiratory rate. Medicine 103 (29) (2024)
Ratoe Suraya, Tatsuya Nagano, Masako Yumura, Tetsuya Hara, Masaya Akashi, Masatsugu Yamamoto, Motoko Tachihara, Yoshihiro Nishimura, Kazuyuki Kobayashi
Loss of JCAD/KIAA1462 Protects the Lung from Acute and Chronic Consequences of Chronic Obstructive Pulmonary Disease. International journal of molecular sciences 25 (17) (2024)
Wiwin Is Effendi, Tatsuya Nagano
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression. International journal of molecular sciences 24 (5) (2023)
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano
Mitochondrial Dysfunction in Pulmonary Hypertension. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Junya Yoshioka, Tatsuya Nagano, Reina Sekiya, Erika Yano, Naoya Hatano, Naoko Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Yuichi Uno, Tatsuya Moriyama, Yoshihiro Nishimura, Kazuyuki Kobayashi
Identification of a 17 kDa protein that is a potentially novel antigen of lettuce-associated respiratory allergy in farmers. Immunity, inflammation and disease 11 (11) (2023)
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano
Mitochondrial Dysfunction in Pulmonary Hypertension. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Wiwin Is Effendi, Tatsuya Nagano
Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation. Biomedicines 11 (4) (2023)
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano
Mitochondrial Dysfunction in Pulmonary Hypertension. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Wiwin Is Effendi, Tatsuya Nagano
Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation. Biomedicines 11 (4) (2023)
Reina Sekiya, Tatsuya Nagano, Tatsuya Moriyama, Aki Kawaguchi, Takafumi Fukui, Chihiro Mimura, Yohei Kimura, Hisashi Ohnishi, Yoshikazu Kotani, Yoshihiro Nishimura
A case of eosinophilic pneumonia induced by lettuce. Respirology case reports 11 (6) (2023)
Wiwin Is Effendi, Tatsuya Nagano
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression. International journal of molecular sciences 24 (5) (2023)
Wiwin Is Effendi, Tatsuya Nagano
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression. International journal of molecular sciences 24 (5) (2023)
Takeo Nakajima, Tatsuya Nagano, Yoshiharu Miyata, Shoko Murakami, Satoshi Mitsuyuki, Yohei Funakoshi, Kimikazu Yakushijin, Hitoshi Horimoto, Yoshihiro Nishimura, Kazuyuki Kobayashi
Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 18 (1) (2022)
Takafumi Fukui, Motoko Tachihara, Tatsuya Nagano, Kazuyuki Kobayashi
Review of Therapeutic Strategies for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer. Cancers 14 (5) (2022)
Ratoe Suraya, Motoko Tachihara, Tatsuya Nagano, Yoshihiro Nishimura, Kazuyuki Kobayashi
Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates. Cancer management and research 14 (2022)
Wiwin Is Effendi, Tatsuya Nagano
Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge. International journal of molecular sciences 23 (11) (2022)
Ratoe Suraya, Tatsuya Nagano, Kazuyuki Kobayashi, Yoshihiro Nishimura
Microbiome as a Target for Cancer Therapy. Integrative cancer therapies 19 (2021)
Takehiro Otoshi, Tatsuya Nagano, Sae Murakami, Takashi Omori, Daisuke Hazama, Naoko Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Yoshihiro Nishimura, Kazuyuki Kobayashi
A randomized crossover pilot study comparing the efficacy of an auto-demand oxygen delivery system with that of a conventional demand oxygen delivery system in patients with chronic respiratory failure. Medicine 100 (37) (2021)
Wiwin Is Effendi, Tatsuya Nagano
The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung Diseases. International journal of molecular sciences 22 (19) (2021)
Wiwin Is Effendi, Tatsuya Nagano
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time. International journal of molecular sciences 23 (1) (2021)
Asuka Yoshizaki, Tatsuya Nagano, Shintaro Izumi, Teruaki Nishiuma, Kyosuke Nakata, Masatsugu Yamamoto, Yuichiro Yasuda, Daisuke Hazama, Kanoko Umezawa, Naoko Katsurada, Motoko Tachihara, Yoshihiro Nishimura, Kazuyuki Kobayashi
Characteristics of the nocturnal desaturation waveform pattern of SpO2 in COPD patients: an observational study. Respiratory research 22 (1) (2021)
Yuichiro Yasuda, Tatsuya Nagano, Shintaro Izumi, Mina Yasuda, Kosuke Tsuruno, Kazunori Tobino, Kyosuke Nakata, Kayoko Okamura, Teruaki Nishiuma, Kiyonobu Takatsuki, Yasuhiro Funada, Hisashi Ohnishi, Masatsugu Yamamoto, Yoshihiro Nishimura, Kazuyuki Kobayashi
Analysis of nocturnal desaturation waveforms using algorithms in patients with idiopathic pulmonary fibrosis. Sleep & breathing = Schlaf & Atmung (2021)
Masako Yumura, Tatsuya Nagano, Yoshihiro Nishimura
Novel Multitarget Therapies for Lung Cancer and Respiratory Disease. Molecules (Basel, Switzerland) 25 (17) (2020)
Ryota Dokuni, Tatsuya Nagano, Naoe Jimbo, Hiroki Sato, Tatsunori Kiriu, Yuichiro Yasuda, Masatsugu Yamamoto, Motoko Tachihara, Kazuyuki Kobayashi, Yoshimasa Maniwa, Yoshihiro Nishimura
High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma. Respiratory research 21 (1) (2020)
Wiwin Is Effendi, Tatsuya Nagano, Kazuyuki Kobayashi, Yoshihiro Nishimura
Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. Cells 9 (3) (2020)
Koichi Furukawa, Tatsuya Nagano, Motoko Tachihara, Masatsugu Yamamoto, Yoshihiro Nishimura
Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer. Molecules (Basel, Switzerland) 25 (17) (2020)
Tatsuya Nagano, Masahiro Katsurada, Yuichiro Yasuda, Kazuyuki Kobayashi, Yoshihiro Nishimura
Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials. Therapeutic advances in respiratory disease 13 (2020)
Nanako Miwa, Tatsuya Nagano, Naoe Jimbo, Ryota Dokuni, Tatsunori Kiriu, Chihiro Mimura, Yuichiro Yasuda, Masahiro Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Yugo Tanaka, Kazuyuki Kobayashi, Tomoo Itoh, Yoshimasa Maniwa, Yoshihiro Nishimura
Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma. OncoTargets and therapy 13 (2020)
Reina Sekiya, Tatsuya Nagano, Tatsuya Moriyama, Toshiyuki Kishi, Haruko Shinke, Erika Yano, Naoya Hatano, Masahiro Katsurada, Kanoko Umezawa, Naoko Katsurada, Suya Hori, Nobuko Hazeki, Atsushi Fukunaga, Masatsugu Yamamoto, Hiroshi Kamiryo, Masakazu Shinohara, Kazuyuki Kobayashi, Yoshikazu Kotani, Yoshihiro Nishimura
Occupational respiratory allergy to lettuce in lettuce farmers. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 50 (8) (2020)
Wiwin Is Effendi, Tatsuya Nagano, Helmia Hasan, Resti Yudhawati
Immunoregulatory Property of C-Type Lectin-Like Receptors in Fibrosing Interstitial Lung Diseases. International journal of molecular sciences 21 (10) (2020)
Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Daisuke Hazama, Reina Sekiya, Masahiro Katsurada, Naoko Katsurada, Motoko Tachihara, Kazuyuki Kobayashi, Yoshihiro Nishimura
Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case-Control Study. OncoTargets and therapy 12 (2019)
Takehiro Otoshi, Tatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
Possible Biomarkers for Cancer Immunotherapy. Cancers 11 (7) (2019)
Tatsuya Nagano, Masahiro Katsurada, Ryota Dokuni, Daisuke Hazama, Tatsunori Kiriu, Kanoko Umezawa, Kazuyuki Kobayashi, Yoshihiro Nishimura
Crucial Role of Extracellular Vesicles in Bronchial Asthma. International journal of molecular sciences 20 (10) (2019)
Yuichiro Yasuda, Tatsuya Nagano, Motoko Tachihara, Norio Chihara, Kanoko Umezawa, Naoko Katsurada, Masatsugu Yamamoto, Kenji Sekiguchi, Kazuyuki Kobayashi, Yoshihiro Nishimura
Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review. Therapeutics and clinical risk management 15 (2019)
Kanoko Umezawa, Tatsuya Nagano, Kazuyuki Kobayashi, Ryota Dokuni, Masahiro Katsurada, Masatsugu Yamamoto, Yoko Yoshikawa, Tohru Kataoka, Yoshihiro Nishimura
Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells. Respiratory research 20 (1) (2019)
Yoshitaka Kawa, Tatsuya Nagano, Asuka Yoshizaki, Ryota Dokuni, Masahiro Katsurada, Tomomi Terashita, Yuichiro Yasuda, Kanoko Umezawa, Masatsugu Yamamoto, Hiroshi Kamiryo, Kazuyuki Kobayashi, Yoshihiro Nishimura
Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells. PloS one 13 (9) (2018)
Tatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy. Cells 7 (11) (2018)
Kei Kunimasa, Tatsuya Nagano, Yohei Shimono, Ryota Dokuni, Tatsunori Kiriu, Shuntaro Tokunaga, Daisuke Tamura, Masatsugu Yamamoto, Motoko Tachihara, Kazuyuki Kobayashi, Miyako Satouchi, Yoshihiro Nishimura
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters. Cancer science 108 (7) (2017)